AI assistant
ADHERIUM LIMITED — Board/Management Information 2021
Oct 18, 2021
64305_rns_2021-10-18_393e8e13-172a-40eb-9f49-22cd5442f47e.pdf
Board/Management Information
Open in viewerOpens in your device viewer
==> picture [211 x 52] intentionally omitted <==
Adherium appoints Robert Spurr as Interim CFO
Melbourne, Australia – 19 October 2021: Adherium Limited (ASX: ADR), a leader in respiratory eHealth, remote monitoring and data management solutions, is pleased to announce the appointment of Mr Robert Spurr as Interim Chief Financial Officer, effective 19 October 2021.
Robert brings a wealth of experience from the energy and infrastructure sectors including seven years as CFO with renewable energy IPP Pacific Hydro. He has worked extensively across Australia, South East Asia and South America with both Orica Ltd and Pacific Hydro including postings to Santiago, Chile, Jakarta, Indonesia and Singapore. Robert holds a Bachelor of Business from Deakin University and is a CPA and a graduate of the Australia Institute of Company Directors.
Robert commented, “I look forward to joining the Adherium team at this important phase of the company’s development.”
Adherium’s Chief Executive Officer Mr Rick Legleiter, remarked, “we are very pleased to have a seasoned executive such as Robert applying his experience and capabilities as bridging support as we progress our recruiting of this Melbourne-based position.”
About Adherium (ASX: ADR)
Adherium is a provider of digital health solutions and a global leader in connected respiratory medical devices, with more than 170,000 sold globally. The Company develops, manufactures and supplies a broad range of connected medical devices for respiratory medications for patients, pharmaceutical companies, healthcare providers and contract research organisations. Adherium’s Hailie® solution is designed to help patients achieve better adherence and provide visibility to parents and caregivers. It does this by tracking medication use and reminding the user with helpful nudges when
Adherium Limited (ACN 605 352 510) Collins Square, Tower 4, Level 18, 727 Collins Street Melbourne VIC 3000 Australia www.adherium.com | www.hailie.com | [email protected]
==> picture [211 x 52] intentionally omitted <==
it is time to take doses, and by providing access to usage history to better understand patterns in their asthma and COPD.
Learn more at www.adherium.com
This ASX announcement was approved and authorised for release by the Board of Adherium.
Enquiries: Rick Legleiter CEO Adherium Limited [email protected]
Adherium Limited (ACN 605 352 510) Collins Square, Tower 4, Level 18, 727 Collins Street Melbourne VIC 3000 Australia www.adherium.com | www.hailie.com | [email protected]